![\"\"](\"https:\/\/mycetoma.edu.sd\/wp-content\/uploads\/2023\/02\/DNDi-MYC-452.jpg\")
<\/p>\n<\/p>\n
<\/p>\n
<\/p>\n
Clinical Trial Group<\/strong> Diagnostics Research Group<\/strong> Development of field-friendly point-of-care diagnostic test for mycetoma<\/strong> Protein Biobank<\/strong> Eumycetoma Molecular Diagnosis<\/strong> Actinomycetoma Molecular Diagnosis<\/strong> In Vitro Drugs Sensitivity Testing<\/strong> Fosravuconazole Pharmacodynamics for Eumycetoma Treatment<\/strong> Epidemiology Research Group<\/strong> Mycetoma Environment Microorganisms Spatial Distribution<\/strong> Mycetoma Genetics<\/strong> Mycetoma Transmission Route and Vector Control<\/strong> Mycetoma Spatial Distribution in Sudan<\/strong> Social Sciences Research Group<\/strong> Immunopathology Research Group<\/strong> Digital Spatial Profiling of the immune- microenvironment in the mycetoma granulomas<\/strong> Immune responses of mycetoma patients during a double-blind, randomised clinical trial for eumycetoma treatment using fosravuconazole versus the current standard of care, daily treatment with itraconazole.<\/strong> Mycetoma Mathematical Modeling<\/strong> The mathematical modelling for the histopathological diagnosis of Mycetoma<\/strong> The mathematical modelling for the mycetoma treatment outcome<\/strong> Drug Repurposing for Mycetoma<\/strong> Global Mycetoma Epidemiological Survey <\/strong> Mycetoma Immunopathological Study <\/strong> Research Groups Clinical Trial Group Lead: Prof Fahal Coordinator: Dr. Eiman Saddig Double-blind, randomised clinical trial for eumycetoma treatment using fosravuconazole versus the current standard of care, daily treatment with itraconazole. MRC- DNDi \u2013 Eisai Ltd (Japan) Group Members Diagnostics Research Group Lead: Dr. Sahar Mubarak Subgroups Development of field-friendly point-of-care diagnostic test […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":14,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2682","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/mycetoma.edu.sd\/index.php?rest_route=\/wp\/v2\/pages\/2682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mycetoma.edu.sd\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mycetoma.edu.sd\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mycetoma.edu.sd\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mycetoma.edu.sd\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2682"}],"version-history":[{"count":6,"href":"https:\/\/mycetoma.edu.sd\/index.php?rest_route=\/wp\/v2\/pages\/2682\/revisions"}],"predecessor-version":[{"id":4896,"href":"https:\/\/mycetoma.edu.sd\/index.php?rest_route=\/wp\/v2\/pages\/2682\/revisions\/4896"}],"wp:attachment":[{"href":"https:\/\/mycetoma.edu.sd\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nLead: Prof Fahal
\nCoordinator: Dr. Eiman Saddig
\nDouble-blind, randomised clinical trial for eumycetoma treatment using fosravuconazole versus the current standard of care, daily treatment with itraconazole.
\nMRC- DNDi \u2013 Eisai Ltd (Japan) Group Members<\/p>\n
\n
\nLead: Dr. Sahar Mubarak
\nSubgroups<\/p>\n
\n
\nMycEXomics Members<\/p>\n
\nMRC \u2013 Biochemistry Department, Faculty of Medicine, U of K Group Members<\/p>\n
\n
\nMRC \u2013 Erasmus Medical Centre Group Members<\/p>\n
\n
\nMRC \u2013 Erasmus Medical Centre Group Members<\/p>\n
\n
\nMRC \u2013 Erasmus Medical Centre Group Members<\/p>\n
\n
\nMRC \u2013 DNDi<\/p>\n
\n
\nLead: Prof Fahal
\nCoordinator: Dr. Sahar Mubarak<\/p>\n
\n
\nMRC, Mycetoma AMED Group<\/p>\n
\n
\nMycetoma spatial distribution at Eastern Sennar<\/strong>
\nMRC \u2013 Nagasaki University, Japan Group Members<\/p>\n
\n
\nMRC \u2013 Vector Genetics and Control Laboratory, Faculty of Science, University of Khartoum Group Members<\/p>\n
\n
\nMRC \u2013 Faculty of Geographical and Environmental Sciences, University of Khartoum Group Members<\/p>\n
\n
\nLead:\u00a0 Dr Azza Ahmed A AZZIZ<\/p>\n
\n
\nLead:\u00a0 Prof. Ahmed Mudawi Musa
\nCoordinator:\u00a0 Dr. Sahar Mubarak<\/p>\n
\n
\nMRC \u2013 Immunity and Infection Centre, York University\u00a0<\/strong><\/p>\n
\n
\nMRC- DNDi \u2013 Eisai Ltd (Japan) Group Members<\/p>\n
\n
\nLead: Prof. Fahal
\nCoordinator: Miss Hayman Omer<\/p>\n
\n
\nMRC \u2013 Tours University, France Group Members<\/p>\n
\n
\nMRC, Comboni University College
\nCoordinator: Miss Hayman Omer<\/p>\n
\n
\nMRC \u2013 Tours University, France Group Members
\nCoordinator: Dr Lamis EL Khair<\/p>\n
\n
\nLead: Dr Dallas Smith
\nCenters for Diseases Control, DNDi, MRC<\/p>\n
\n
\nMRC, Global Mycetoma Working Group<\/p>\n","protected":false},"excerpt":{"rendered":"